Evidence map›Paper›PMID 37099213›Full record

ReviewAdvances in therapy2023

Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ).

Stacie Hudgens, Andrea Phillips-Beyer, Louise Newton, Dalma Seboek Kinter, Heike Benes

Open access · hybridAbstract readReview
In one paragraph

Review in Advances in therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Stacie HudgensClinical Outcomes Solutions, Tucson, AZ, USA.
Andrea Phillips-BeyerInnovus Consulting Ltd., London, UK. andrea.beyer@ext.idorsia.com.
Louise NewtonClinical Outcomes Solutions, Tucson, AZ, USA.
Dalma Seboek KinterIdorsia Pharmaceuticals Ltd., Allschwil, Switzerland.
Heike BenesSomni Bene Institut Für Medizinische Forschung und Schlafmedizin Schwerin GmbH, Schwerin, Germany.
Health Outcomes Solutions (United States) · USHelios Hospital Schwerin · DEIdorsia (Switzerland) · CHInnovate UK · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is a summary of the original article 'Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)'. Individuals with insomnia are best positioned to assess the impact of insomnia on their quality of life. Patient reported outcomes (PROs) are self-reported health measures created to allow people to record their experience of their disease. Chronic insomnia has a major impact on daytime functioning for patients, and on their quality of life. This summary of research provides an overview of a previously published article detailing the development and evaluation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ), as a tool to allow people with insomnia to report their experience of the impact on their daytime functioning.

Indexed as

Sleep Initiation and Maintenance DisordersHumansQuality of LifeSelf ReportSurveys and Questionnaires

Identifiers

PMID37099213
PMCPMC10219861
OpenAlexW4367047778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.